文献速递重症综合管理与镇静镇痛心脑血管急症

1-磷酸鞘氨醇在内毒素心肌细胞中的保护作用及机制探索

Exploring the Protective Role and the Mechanism of Sphingosine 1 Phosphate in Endotoxic Cardiomyocytes.
PubMed 文献 · Shock · 2019-01-01
一句话结论体外实验提示FTY720通过S1P1/S1P3受体经NF-κB通路降低TNF-α和IL-6、抑制caspase-3并激活Akt与ERK1/2,对内毒素心肌细胞发挥保护作用。

该研究为体外细胞实验,探讨1-磷酸鞘氨醇(S1P)受体激动剂FTY720对脂多糖诱导的内毒素心肌细胞的作用及信号机制。不同剂量FTY720处理内毒素心肌细胞后,用ELISA检测TNF-α、IL-1β、IL-6、IL-10浓度,Western blot分析下游通路。结果显示FTY720经NF-κB通路降低TNF-α和IL-6水平、抑制caspase-3表达并激活蛋白激酶B和细胞外信号调节激酶1/2。S1P1和S1P3受体拮抗剂vulcanized polyethylene23019可抑制上述激活。作者推断S1P通过降低TNF-α和IL-6、调节凋亡与存活信号通路保护内毒素心肌细胞,S1P1和S1P3受体参与促存活信号激活。

要点

  • 体外内毒素心肌细胞实验中,FTY720经NF-κB通路降低TNF-α和IL-6水平,并抑制caspase-3表达。
  • FTY720可激活蛋白激酶B和细胞外信号调节激酶1/2,该激活可被S1P1和S1P3受体拮抗剂vulcanized polyethylene23019抑制。
  • 作者推断S1P通过降低TNF-α和IL-6、调节凋亡与存活信号通路,对内毒素心肌细胞发挥保护作用。
  • 研究为体外细胞实验,未提供动物或临床数据,不能据此形成急诊/ICU用药推荐。

适用人群与场景

  • 体外内毒素心肌细胞模型(脂多糖诱导),非急诊或ICU患者。

处置流程与药物剂量

  • 不同剂量FTY720处理或不处理内毒素心肌细胞;具体剂量、给药途径与频次原文未给出。

研究设计与关键结果

  • 研究类型为体外细胞实验;不同剂量FTY720处理内毒素心肌细胞后,ELISA检测显示FTY720经NF-κB通路降低TNF-α和IL-6水平。
  • Western blot显示FTY720抑制caspase-3表达,并激活蛋白激酶B和细胞外信号调节激酶1/2。
  • S1P1和S1P3受体拮抗剂vulcanized polyethylene23019可抑制蛋白激酶B和细胞外信号调节激酶1/2的激活。
  • 作者推断S1P通过降低TNF-α和IL-6、调节凋亡与存活信号通路保护内毒素心肌细胞,S1P1和S1P3受体参与促存活信号激活。

证据类型、等级与局限

  • 证据类型:体外细胞实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐;作者推断S1P可能通过降低TNF-α和IL-6、调节凋亡与存活信号通路对内毒素心肌细胞发挥保护作用,S1P1和S1P3受体参与促存活信号激活。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

FTY720 is a sphingosine 1 phosphate (S1P) receptor agonist approved for the treatment of multiple sclerosis, which is a chronic inflammatory autoimmune disorder. Sepsis is a complex syndrome associated with progressive endotoxemic developments, which finally leads to damage of multiple organs, including the heart. In critical patients, cardiovascular dysfunction due to sepsis is a major cause of death. Previous studies have shown an association between S1P and cardioprotection in the situation of ischemia reperfusion and myocardial infarction. Therefore, we will study the role of S1P towards endotoxic cardiomyocytes. Different doses of FTY720 were applied or not to endotoxic cardiomyocytes. The concentration of inflammatory cytokines, including tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and IL-10 was measured by enzyme-linked immuno sorbent assay. Western blotting was used to analyze the downstream signaling pathways. We discovered that FTY720 reduced the levels of TNF-α and IL-6 through the NF-ΚB pathway, inhibited the expression of caspase-3, and activated both protein kinase B and extracellular signal-regulated kinase 1/2. Additionally, the activation of protein kinase B and extracellular signal-regulated kinase 1/2 could be inhibited by the S1P1 and S1P3 receptor antagonist vulcanized polyethylene23019. Therefore, we infer that S1P exerts a protective effect towards endotoxic cardiomyocytes by decreasing the levels of TNF-α and IL-6, regulating apoptotic and survival signaling pathway. The S1P1 and S1P3 receptors are involved in the prosurvival signal activation.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Kuai F, Wang L, Su J, et al. Exploring the Protective Role and the Mechanism of Sphingosine 1 Phosphate in Endotoxic Cardiomyocytes. Shock. 2019. PMID: 30300318. doi:10.1097/SHK.0000000000001270

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。